title: Regulations and procedures for new drug evaluation and approval in China.
authors.affiliation: Division of Biological Products, Department of Drug Registration, State Food and Drug Administration of China, Beijing, China. yinhz@sda.gov.cn
authors.forename: Hongzhang
authors.initials: H
authors.lastname: Yin
mesh_terms: D002681:China; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004341:Drug Evaluation / Q000331:legislation & jurisprudence* / Q000379:methods; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D017387:Investigational New Drug Application / Q000331:legislation & jurisprudence*; D007880:Legislation, Drug